Stay updated on TGRX-326 Chinese Phase I Clinical Trial

Sign up to get notified when there's something new on the TGRX-326 Chinese Phase I Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TGRX-326 Chinese Phase I Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    This updates the displayed application/version revision for the ClinicalTrials.gov page from v3.5.2 to v3.5.3 without altering the study record’s content. The record history list of submissions remains the same.
    Difference
    0.1%
    Check dated 2026-04-24T06:24:41.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:44:24.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Sponsor entity updated from Shenzhen TargetRx, Inc. to Shenzhen TargetRx Co., Ltd.
    Difference
    0.2%
    Check dated 2026-03-26T11:47:12.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Contacts/Locations and Sponsor/Collaborators sections were added; the record history shows revision to v3.5.0 (replacing v3.4.3).
    Difference
    0.3%
    Check dated 2026-03-19T06:11:19.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3; removed Revision: v3.4.2 from the Record History.
    Difference
    0.1%
    Check dated 2026-03-12T02:15:33.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the study record history. Removed the funding-lapse notice and Revision: v3.4.1.
    Difference
    0.9%
    Check dated 2026-02-11T11:28:16.000Z thumbnail image

Stay in the know with updates to TGRX-326 Chinese Phase I Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TGRX-326 Chinese Phase I Clinical Trial page.